Adoption of a “Pathogenic, Predisposing, Risk and Benign” classification of DNA variants for precision medicine – a step forward

Authors

DOI:

https://doi.org/10.69734/h7x6zm57

Keywords:

genetic, complex trait genetics, pathogenic variant , risk variant, polygenic risk score, predisposing variant, ACMG, variant of unknown significance, precision medicine

Abstract

Precision medicine is often at odds with medical genetics in classifying gene mutations that have high impact on protein expression or function but do not “cause” disease.  A new proposal aims to expand the terminology for genetic variants along a spectrum:

(1) pathogenic (retaining Medical Genetics meaning)

(2) predisposing (new term)

(3) risk (as used in PRS)

(4) benign (used in contrast to “pathogenic” but may be “predisposing” in some circumstances and context)

This framework bridges the gap between binary classifications and the nuanced reality of variant effects, paving the way for more accurate risk assessment in clinical practice.  

It is time for adoption by geneticists and major professional societies. 

References

Girodon E, Rebours V, Chen JM, Pagin A, Levy P, Ferec C, et al. Clinical interpretation of SPINK1 and CTRC variants in pancreatitis. Pancreatology. 2020;20(7):1354-67 D.O.I: 10.1016/j.pan.2020.09.001. PMID: 32948427

LaRusch J, Lozano-Leon A, Stello K, Moore A, Muddana V, O'Connell M, et al. The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population. Clin Transl Gastroenterol. 2015;6:e68 D.O.I: 10.1038/ctg.2014.13. PMID: 25569187

Wang QW, Zou WB, Masson E, Ferec C, Liao Z, Chen JM. Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer. Hum Genomics. 2025;19(1):32 D.O.I: 10.1186/s40246-025-00740-x. PMID: 40140953

Waqar M, Whitcomb DC, Rebours V. SPINK1 Genetic Variants in Pancreatitis. SMART-MD JPM. 2025;2(1):e93-e101 D.O.I: https://doi.org/doi.org/10.69734/tbx0n188

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-24 D.O.I: 10.1038/gim.2015.30. PMID: 25741868

Whitcomb DC. Primer on Precision Medicine for Complex Chronic Disorders. Clin Transl Gastroenterol. 2019;10(7):e00067 D.O.I: 10.14309/ctg.0000000000000067. PMID: 31335357

Tomas JP, Modos D, Korcsmaros T, Brooks-Warburton J. Network Biology Approaches to Achieve Precision Medicine in Inflammatory Bowel Disease. Front Genet. 2021;12:760501 D.O.I: 10.3389/fgene.2021.760501. PMID: 34745229

Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-53 D.O.I: 10.1038/nature08494. PMID: 19812666

Greer P, DeFrancesco-Oranburg T. SMART-Topic: Polygenic Risk Score (PRS): Development, Interpretation and Utility. SMART-MD JPM.2(3):e171 - e6 D.O.I: https://doi.org/10.69734/sqe1mp91.

Wang YC, Masson E, Wang QW, Genin E, Le Gac G, Fichou Y, et al. SPINK1-related chronic pancreatitis: A model that encapsulates the spectrum of variant effects, genetic complexity, and classificatory challenges. Am J Hum Genet. 2025 D.O.I: 10.1016/j.ajhg.2025.07.013. PMID: 40845847

Schirru E, Rossino R, Diana D, Jores RD, Baldera D, Muntoni S, et al. HLA Genotyping in Children With Celiac Disease Allows to Establish the Risk of Developing Type 1 Diabetes. Clin Transl Gastroenterol. 2024;15(7):e00710 D.O.I: 10.14309/ctg.0000000000000710. PMID: 38713138

Cohen R, Mahlab-Guri K, Atali M, Elbirt D. Viruses and celiac disease: what do we know ? Clin Exp Med. 2023;23(7):2931-9 D.O.I: 10.1007/s10238-023-01070-9. PMID: 37103650

Quigley EM. SMART-Approach Closing the genetic gap in Celiac disease. SMART-MD JPM. 2025;2(3):e158-e61 D.O.I: https://doi.org/10.69734/ze7qg483.

Published

2025-09-19

How to Cite

Whitcomb, D. C. (2025). Adoption of a “Pathogenic, Predisposing, Risk and Benign” classification of DNA variants for precision medicine – a step forward. SMART-MD Journal of Precision Medicine, 2(3), e i - ii. https://doi.org/10.69734/h7x6zm57